The effectiveness of Reslizumab in severe asthma treatment: a real-world experience

BACKGROUND: Increased numbers of blood and sputum eosinophils are associated with higher exacerbation frequency and increased asthma severity. In clinical trials, targeting Interleukin-5 has been shown to be a useful therapeutic strategy for patients with severe eosinophilic asthma. METHODS: Twenty-...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Respir Res
Main Authors: Ibrahim, H., O’Sullivan, R., Casey, D., Murphy, J., MacSharry, J., Plant, B. J., Murphy, D. M.
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2019
Teme:
Letter to the Editor
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6923853/
https://ncbi.nlm.nih.gov/pubmed/31861993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-019-1251-3
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki